The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Open accessAbstract
The ErbB2 ( Her2 ) proto-oncogene encodes a receptor tyrosine kinase, which is frequently amplified and overexpressed in human tumors. ErbB2 provides the target for a novel and effective antibody-based therapy (Trastuzumab/Herceptin) used for the treatment of mammary carcinomas. However, cardiomyopathies develop in a proportion of patients treated with Trastuzumab, and the incidence of such complications is increased by combination with standard chemotherapy. Gene ablation studies have previously demonstrated that the ErbB2 receptor, together with its coreceptor ErbB4 and the ligand Neuregulin-1, are essential for normal development of the heart ventricle. We use here Cre- lox P technology to mutate ErbB2 specifically in ventricular cardiomyocytes. Conditional mutant mice develop a severe dilated cardiomyopathy, with signs of cardiac dysfunction generally appearing by the second postnatal month. We infer that signaling from the ErbB2 receptor, which is enriched in T-tubules in cardiomyocytes, is crucial for adult heart function. Conditional ErbB2 mutant mice provide a model of dilated cardiomyopathy. In particular, they will allow a rigorous assessment of the role of ErbB2 in the heart and provide insight into the molecular mechanisms that underlie the adverse effects of anti-ErbB2 antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Multiple essential functions of neuregulin in development
Meyer, D., & Birchmeier, C. (1995) · Nature · doi:10.1038/378386a0 · Cited by 1,262
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,001
Signaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
Self-citationHirota, H., Chen, J., Betz, U. A. K., Rajewsky, K., Gu, Y., Ross, J., Müller, W., & Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80729-1 · Cited by 656
Self-citationNonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
Sliwkowski, M. X., Ja, L., Gd, L., Te, H., FENDLY, B. M., & Fox, J. A. (1999) · PubMed · Cited by 653
Z/AP, a Double Reporter for Cre-Mediated Recombination
Lobe, C. G., Koop, K. E., Kreppner, W., Lomeli, H., Gertsenstein, M., & Nagy, A. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9209 · Cited by 528
Schaper, J., Froede, R., Hein, S., Buck, A., Hashizume, H., Speiser, B., Friedl, A., & Bleese, N. (1991) · Circulation · doi:10.1161/01.cir.83.2.504 · Cited by 521
Neuregulins Promote Survival and Growth of Cardiac Myocytes
Zhao, Y.-Y., Sawyer, D. R., Baliga, R. R., Opel, D. J., Han, X., Marchionni, M. A., & Kelly, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10261 · Cited by 504
Gschwind, A., Zwick, E., Prenzel, N., Leserer, M., & Ullrich, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204192 · Cited by 462
Stress Pathways and Heart Failure
Chien, K. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80043-4 · Cited by 446
Self-citationReceptor-mediated Regulation of the Nonselective Cation Channels TRPC4 and TRPC5
Schaefer, M., Plant, T. D., Obukhov, A. G., Hofmann, T., Gudermann, T., & Schultz, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17517 · Cited by 420
Binding specificities and affinities of egf domains for ErbB receptors
Jones, J. T., Akita, R. W., & Sliwkowski, M. X. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00283-5 · Cited by 381
Wettschureck, N., Rütten, H., Zywietz, A., Gehring, D., Wilkie, T. M., Chen, J., Chien, K. R., & Offermanns, S. (2001) · Nature Medicine · doi:10.1038/nm1101-1236 · Cited by 373
Self-citationBritsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C., & Riethmacher, D. (1998) · Genes & Development · doi:10.1101/gad.12.12.1825 · Cited by 344
Self-citationSoeller, C., & Cannell, M. B. (1999) · Circulation Research · doi:10.1161/01.res.84.3.266 · Cited by 331
ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor
Borg, J.-P., Marchetto, S., Le Bivic, A., Ollendorff, V., Jaulin-Bastard, F., Saito, H., Fournier, E., Adélaïde, J., Margolis, B., & Birnbaum, D. (2000) · Nature Cell Biology · doi:10.1038/35017038 · Cited by 311
Chen, B. P. C., Wolfgang, C. D., & Hai, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1157 · Cited by 308
Molecular targets for breast cancer therapy and prevention
Bange, J., Zwick, E., & Ullrich, A. (2001) · Nature Medicine · doi:10.1038/87872 · Cited by 288
Neuregulin, a factor with many functions in the life of a Schwann cell
Garratt, A. N., Britsch, S., & Birchmeier, C. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<987::aid-bies5>3.0.co;2-5 · Cited by 288
Self-citationThe role of cytoskeletal proteins in cardiomyopathies
Towbin, J. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80096-3 · Cited by 273
A Dual Role of erbB2 in Myelination and in Expansion of the Schwann Cell Precursor Pool
Garratt, A. N., Voiculescu, O., Topilko, P., Charnay, P., & Birchmeier, C. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.5.1035 · Cited by 264
Self-citationLemke, G. (1996) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1996.0019 · Cited by 223
Friddle, C. J., Koga, T., Rubin, E. M., & Bristow, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127897 · Cited by 201
Selective Requirement of Myosin Light Chain 2v in Embryonic Heart Function
Chen, J., Kubalak, S. W., Minamisawa, S., Price, R. L., Becker, K. D., Hickey, R., Ross, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.1252 · Cited by 179
Self-citationDilated and Failing Cardiomyopathy in Bradykinin B2Receptor Knockout Mice
Emanueli, C., Maestri, R., Corradi, D., Marchione, R., Minasi, A., Tozzi, M. G., Salis, M. B., Straino, S., Capogrossi, M. C., Olivetti, G., et al. (1999) · Circulation · doi:10.1161/01.cir.100.23.2359 · Cited by 171
The internal and external protein scaffold of the T-tubular system in cardiomyocytes
Kostin, S., Scholz, D., Shimada, T., et al. (1998) · Cell and Tissue Research · doi:10.1007/s004410051196 · Cited by 149
Rohrbach, S., Yan, X., Weinberg, E. O., Hasan, F., Bartúnek, J., Marchionni, M. A., & Lorell, B. H. (1999) · Circulation · doi:10.1161/01.cir.100.4.407 · Cited by 145
Ablation of Serotonin 5-HT2BReceptors in Mice Leads to Abnormal Cardiac Structure and Function
Nebigil, C. G., Hickel, P., Messaddeq, N., Vonesch, J., Douchet, M.-P., Monassier, L., György, K., Matz, R. L., Andriantsitohaina, R., Manivet, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.24.2973 · Cited by 144
Growth Factor-specific Signaling Pathway Stimulation and Gene Expression Mediated by ErbB Receptors
Sweeney, C. A., Fambrough, D., Huard, C., Diamonti, A. J., Lander, E. S., Cantley, L. C., & Carraway, K. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100602200 · Cited by 123
Should Dukes' B patients receive adjuvant therapy? A statistical perspective
Buyse, M. E., & Piedbois, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90247-7 · Cited by 109
Okamoto, Y., Chaves, A., Chen, J., Kelley, R., Jones, K., Weed, H. G., Gardner, K. L., Gangi, L., Yamaguchi, M., Klomkleaw, W., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61735-x · Cited by 103
Jaulin‐Bastard, F., Saito, H., Bivic, A. L., Ollendorff, V., Marchetto, S., Birnbaum, D., & Borg, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010032200 · Cited by 100
Hertig, C. M., Kubalak, S. W., Wang, Y., & Chien, K. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37362 · Cited by 94
Self-citationAcute Suppression of Inwardly Rectifying Kir2.1 Channels by Direct Tyrosine Kinase Phosphorylation
Wischmeyer, E., Döring, F., & Karschin, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34063 · Cited by 94
Cardiac toxicity of trastuzumab (Herceptin): Implications for the design of adjuvant trials
Sparano, J. A. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90189-7 · Cited by 93
Identification of genes regulated during mechanical load-induced cardiac hypertrophy.
Johnatty, S., Dyck, J., Michael, L., Olson, E., & Abdellatif, M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1122 · Cited by 82
Genetically Engineered Models with Alterations in Cardiac Membrane Calcium-Handling Proteins
Kiriazis, H., & Kranias, E. G. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.321 · Cited by 80
Localization and modulation of ErbB receptor tyrosine kinases
Carraway, K. L., & Sweeney, C. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00188-5 · Cited by 58
Cardiomyopathies and their role in sudden death
Brandenburg, R. O. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80553-2 · Cited by 29
The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Hainsworth, J. D., & Greco, F. (1999) · PubMed · Cited by 18
Cited by
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Cardiovascular Complications of Cancer Therapy
Yeh, E. T. H., & Bickford, C. L. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.050 · Cited by 1,275
Neuregulins: functions, forms, and signaling strategies
Falls, D. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00102-7 · Cited by 1,071
Metadata
- Authors
- Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-06-18
- Volume
- 99
- Issue
- 13
- Pages
- 8880-8885
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1983530651
- Cited by
- 473
- References
- 44
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.